Raras
Buscar doenças, sintomas, genes...
Síndrome Sjögren-Larsson
ORPHA:816CID-10 · Q87.1CID-11 · 5C52.03OMIM 270200DOENÇA RARA

Uma condição que afeta a pele, o cérebro e os nervos, causada por um erro genético no processamento de gorduras pelo corpo. É caracterizada por pele seca, grossa e escamosa desde o nascimento, dificuldade de aprendizado e rigidez muscular.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma condição que afeta a pele, o cérebro e os nervos, causada por um erro genético no processamento de gorduras pelo corpo. É caracterizada por pele seca, grossa e escamosa desde o nascimento, dificuldade de aprendizado e rigidez muscular.

Pesquisas ativas
1 ensaio
3 total registrados no ClinicalTrials.gov
Publicações científicas
397 artigos
Último publicado: 2026 Apr 1

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
16.0
Taiwan, Province of China
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q87.1
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
13 sintomas
🧠
Neurológico
8 sintomas
🧬
Pele e cabelo
6 sintomas
🦴
Ossos e articulações
6 sintomas
🦷
Dentes
2 sintomas
💪
Músculos
1 sintomas

+ 11 sintomas em outras categorias

Características mais comuns

100%prev.
Espasticidade
Muito frequente (99-80%)
100%prev.
Ictiose
Muito frequente (99-80%)
100%prev.
Deficiência intelectual
Muito frequente (99-80%)
100%prev.
Acuidade visual reduzida
Frequência: 19/19
100%prev.
Contratura em flexão
Frequência: 6/6
100%prev.
Cristais maculares
Frequência: 9/9
47sintomas
Muito frequente (18)
Frequente (13)
Ocasional (8)
Muito raro (2)
Sem dados (6)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 47 características clínicas mais associadas, ordenadas por frequência.

EspasticidadeSpasticity
Muito frequente (99-80%)100%
IctioseIchthyosis
Muito frequente (99-80%)100%
Deficiência intelectualIntellectual disability
Muito frequente (99-80%)100%
Acuidade visual reduzidaReduced visual acuity
Frequência: 19/19100%
Contratura em flexãoFlexion contracture
Frequência: 6/6100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico397PubMed
Últimos 10 anos90publicações
Pico201814 papers
Linha do tempo
2026Hoje · 2026🧪 2015Primeiro ensaio clínico📈 2018Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

ALDH3A2Aldehyde dehydrogenase family 3 member A2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the oxidation of medium and long chain aliphatic aldehydes to fatty acids. Active on a variety of saturated and unsaturated aliphatic aldehydes between 6 and 24 carbons in length (PubMed:18035827, PubMed:18182499, PubMed:22633490, PubMed:25047030, PubMed:9133646, PubMed:9662422). Responsible for conversion of the sphingosine 1-phosphate (S1P) degradation product hexadecenal to hexadecenoic acid (PubMed:22633490)

LOCALIZAÇÃO

Microsome membraneEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
RND1 GTPase cycleRND2 GTPase cycle
MECANISMO DE DOENÇA

Sjoegren-Larsson syndrome

An autosomal recessive neurocutaneous disorder characterized by a combination of severe intellectual disability, spastic di- or tetraplegia and congenital ichthyosis. Ichthyosis is usually evident at birth with varying degrees of erythema and scaling, neurologic symptoms appear in the first or second year of life. Most patients have an IQ of less than 60. Additional clinical features include glistening white spots on the retina, seizures, short stature and speech defects.

OUTRAS DOENÇAS (1)
Sjogren-Larsson syndrome
HGNC:403UniProt:P51648

Variantes genéticas (ClinVar)

301 variantes patogênicas registradas no ClinVar.

🧬 ALDH3A2: GRCh38/hg38 17p11.2(chr17:16832948-20527478)x1 ()
🧬 ALDH3A2: NM_000382.3(ALDH3A2):c.638dup (p.Cys214fs) ()
🧬 ALDH3A2: NM_000382.3(ALDH3A2):c.1258del (p.Ser420fs) ()
🧬 ALDH3A2: GRCh37/hg19 17p11.2(chr17:19494804-19563018)x0 ()
🧬 ALDH3A2: NM_000382.3(ALDH3A2):c.1040del (p.Glu347fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 255 variantes classificadas pelo ClinVar.

38
217
Patogênica (14.9%)
VUS (85.1%)
VARIANTES MAIS SIGNIFICATIVAS
ALDH3A2: NM_000382.3(ALDH3A2):c.1258del (p.Ser420fs) [Pathogenic]
ALDH3A2: NM_000382.3(ALDH3A2):c.1040del (p.Glu347fs) [Likely pathogenic]
ALDH3A2: NM_000382.3(ALDH3A2):c.342del (p.Phe115fs) [Likely pathogenic]
ALDH3A2: NM_000382.3(ALDH3A2):c.946A>G (p.Thr316Ala) [Uncertain significance]
ALDH3A2: NM_000382.3(ALDH3A2):c.1153G>A (p.Gly385Ser) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 22
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 3 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Sjögren-Larsson

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

3 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
83 papers (10 anos)
#1

Multisystem manifestations of Sjögren-Larsson syndrome in early childhood and its dental implications.

BMJ case reports2026 Mar 13

Sjögren-Larsson syndrome (SLS) constitutes a rare genetic disorder manifesting as a complex neurocutaneous condition characterised by congenital ichthyosis, progressive neurological impairment and intellectual disability. This case report presents an early childhood female patient exhibiting the classic triad of symptoms, along with significant oral complications, including severe dental caries, enamel demineralisation and gingivitis. Molecular genetic testing confirmed a homozygous pathogenic variant in the ALDH3A2 (Aldehyde Dehydrogenase 3 family member 2) gene, establishing the diagnosis. The patient's management encompassed a comprehensive multidisciplinary approach, integrating dental interventions under general anaesthesia, systemic therapies for spasticity and cutaneous manifestations, and regular follow-up care. This case highlights the critical importance of recognising oral manifestations in SLS and emphasises the need for integrated oral healthcare within the broader therapeutic framework for affected individuals.

#2

General Anesthesia for a Child With Sjögren-Larsson Syndrome.

Anesthesia progress2026 Mar 06

This case report describes the dental treatment performed under general anesthesia for a boy with Sjögren-Larsson syndrome (SLS), a rare autosomal recessive genetic disorder. The main symptoms of SLS are congenital ichthyosis, limb paraplegia or tetraplegia, and intellectual disability. The main concerns regarding the administration of general anesthesia to patients with SLS include difficulty with adhesion of the electrocardiogram electrodes and intravenous (IV) catheter dressings due to ichthyosis and heat intolerance secondary to hypohidrosis. Although it was first described approximately 70 years ago, there is little in the existing literature on general anesthesia for patients with SLS. We administered deep sedation/general anesthesia using continuous IV infusions of propofol and remifentanil along with a laryngeal mask airway in a 6-year-old boy with SLS to successfully obtain radiographic studies and extract a supernumerary tooth. No problems occurred other than difficulties with adhesives and soft tissue obstruction of the airway.

#3

Dupilumab Reduces Pruritus in Twins With Sjögren-Larsson Syndrome.

Pediatric dermatology2025 Oct 05

Sjögren-Larsson Syndrome (SLS), now termed ALDH3A2-syndromic epidermal differentiation disorder (sEDD), is a rare genetic disorder marked by thickened skin, spasticity, and intellectual disability. Intractable pruritus is a nearly universal and debilitating feature of SLS that remains poorly managed by current therapies. We describe 4-year-old twin girls with genetically confirmed SLS who showed significant and lasting improvement in itch following treatment with dupilumab, a biologic targeting interleukin-4 receptor signaling. Within 6 months, pruritus severity scores declined markedly, improving sleep and quality of life without adverse effects, supporting further investigation of dupilumab for SLS-associated itch.

#4

Ciliopathy: Sjögren-Larsson Syndrome.

Advances in experimental medicine and biology2025

Sjögren-Larsson syndrome is caused by a mutation in the ALDH3A2 gene, which produces fatty aldehyde dehydrogenase (FALDH). FALDH is a membrane-bound protein involved in fatty oxidation. Structural disturbance and poor metabolite clearance likely contribute to pathogenesis.

#5

Biosynthesis of fatty aldehydes and alcohols in the eye and their role in meibogenesis.

The Journal of biological chemistry2025 Jul

Fatty alcohols (FAlc) and aldehydes (FAld) are essential intermediates/precursors in the biosynthesis of lipids. However, elevated FAld levels were shown to be geno- and cytotoxic, thus requiring conversion into less toxic FAlc and fatty acids (FA). An increase in FAlc and FAld in tissues of patients with Sjögren-Larsson syndrome was reported before and repeatedly linked to inactivation of ALDH3A2, which oxidizes FAld in FA. Recently, we hypothesized that another group of enzymes, namely SDR16C5/SDR16C6 (EC 1.1.1.105), could control the balance between FA, FAlc, and FAld via a separate mechanism. In this study, we assessed the in vivo biosynthesis of FAlc and FAld in mammals using Meibomian glands (MG) of wild-type (WT) and Sdr16c5/Sdr16c6-null (Hom) mice as models. Lipids were extracted from MG of experimental animals and analyzed using LC/MS. Because of high reactivity and instability of FAld, the compounds were initially converted to stable, sodium borohydride-reduced 3-aminopyridine conjugates, while FAlc were analyzed as N-alkyl pyridinium ions. A wide range of saturated and unsaturated FAld, FAlc, and FA ranging from C3 to C28 and longer were found in MG of mice of both genotypes. Our experiments revealed a multifold upregulation of almost all detected straight chain, but not branched, FAlc in MG lipidomes of Hom mice, which implied a previously unknown ability of SDR16C5/SDR16C6 to oxidize a wide range of FAlc in FAld in vivo. We have concluded that SDR16C5/SDR16C6 plays a central, and selective, role in FA/FAlc/FAld metabolism in vivo and proposed a generalized mechanism of these reactions.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC326 artigos no totalmostrando 89

2026

Multisystem manifestations of Sjögren-Larsson syndrome in early childhood and its dental implications.

BMJ case reports
2026

General Anesthesia for a Child With Sjögren-Larsson Syndrome.

Anesthesia progress
2025

Dupilumab Reduces Pruritus in Twins With Sjögren-Larsson Syndrome.

Pediatric dermatology
2025

Ciliopathy: Sjögren-Larsson Syndrome.

Advances in experimental medicine and biology
2025

Biosynthesis of fatty aldehydes and alcohols in the eye and their role in meibogenesis.

The Journal of biological chemistry
2025

Accumulation of ether phospholipids in induced pluripotent stem cells and oligodendrocyte-lineage cells established from patients with Sjögren-Larsson syndrome.

Congenital anomalies
2024

Discovery of novel diagnostic biomarkers for Sjögren-Larsson syndrome by untargeted lipidomics.

Biochimica et biophysica acta. Molecular and cell biology of lipids
2023

Coexistence of Ichthyosis, Yellowish Keratoderma, and Neurologic Manifestations: Think About Sjogren-Larsson Syndrome.

Skinmed
2023

Sjogren-Larsson syndrome brain volumetric reductions demonstrated with an automated software.

Arquivos de neuro-psiquiatria
2023

Untargeted Metabolomic Analysis of Sjögren-Larsson Syndrome Reveals a Distinctive Pattern of Multiple Disrupted Biochemical Pathways.

Metabolites
2022

End-stage crystalline maculopathy with retinal atrophy in Sjögren-Larsson syndrome: a case report and review of the literature.

Therapeutic advances in rare disease
2023

Sjögren-Larsson Syndrome: A Rare Presentation With Developmental Delay.

Cureus
2023

Clinical and molecular characteristics of autosomal recessive congenital ichthyosis in Thailand.

Pediatric dermatology
2023

Sjögren-Larsson syndrome caused by novel mutations in ALDH3A2 gene.

International journal of dermatology
2022

Ceramide profiling of stratum corneum in Sjögren-Larsson syndrome.

Journal of dermatological science
2022

Small touches to big walks -the impact of rehabilitation on Sjögren-Larsson syndrome: A case report.

Journal of pediatric rehabilitation medicine
2022

Beyond retina in Sjogren-Larsson syndrome.

Indian journal of ophthalmology
2022

Retinal Capillary Abnormalities in Sjögren-Larsson Syndrome Maculopathy.

Case reports in ophthalmology
2022

Sjögren-Larsson syndrome: A biochemical rationale for using aldehyde-reactive therapeutic agents.

Molecular genetics and metabolism reports
2021

Impaired Skin Barrier Function Due to Reduced ω-O-Acylceramide Levels in a Mouse Model of Sjögren-Larsson Syndrome.

Molecular and cellular biology
2021

Sjögren-Larsson syndrome in Spain: Description of three new cases.

Anales de pediatria
2021

A Neurodegenerative Phenotype Associated With Sjögren-Larsson Syndrome.

Journal of child neurology
2021

Novel ALDH3A2 mutations in structural and functional domains of FALDH causing diverse clinical phenotypes in Sjögren-Larsson syndrome patients.

Human mutation
2021

Muscle Tone Assessment under General Anesthesia for Sjögren-Larsson Syndrome and Spasticity.

Pediatric neurosurgery
2020

Aldh1l2 knockout mouse metabolomics links the loss of the mitochondrial folate enzyme to deregulation of a lipid metabolism observed in rare human disorder.

Human genomics
2020

Sjögren-Larsson syndrome: Anesthetic considerations and practical recommendations.

Paediatric anaesthesia
2020

Sjogren-Larsson Syndrome: A case series of five members from an extended family with a novel mutation.

Molecular genetics &amp; genomic medicine
2020

1-O-Alkylglycerol accumulation reveals abnormal ether glycerolipid metabolism in Sjögren-Larsson syndrome.

Molecular genetics and metabolism
2020

Disturbed brain ether lipid metabolism and histology in Sjögren-Larsson syndrome.

Journal of inherited metabolic disease
2020

Macular crystalline inclusions in Sjögren-Larsson syndrome are dynamic structures that undergo remodeling.

Ophthalmic genetics
2020

Sjögren-Larsson syndrome: The mild end of the phenotypic spectrum.

JIMD reports
2020

Comprehensive Molecular Profiles of Functionally Effective MSC-Derived Extracellular Vesicles in Immunomodulation.

Molecular therapy : the journal of the American Society of Gene Therapy
2020

Comprehensive in silico screening and molecular dynamics studies of missense mutations in Sjogren-Larsson syndrome associated with the ALDH3A2 gene.

Advances in protein chemistry and structural biology
2020

Sjogren-Larsson Syndrome: Mechanisms and Management.

The application of clinical genetics
2020

Next-generation sequencing through multi-gene panel testing for diagnosis of hereditary ichthyosis in Chinese.

Clinical genetics
2020

Compound heterozygous mutations in the ALDH3A2 gene cause Sjögren-Larsson syndrome: a case report.

The International journal of neuroscience
2020

Novel imaging technologies for genetic diagnoses in the inborn errors of metabolism.

Journal of translational genetics and genomics
2020

Sjogren-Larsson syndrome associated hypermelanosis.

Journal of cosmetic dermatology
2019

Sjögren-Larsson syndrome: a complex metabolic disease with a distinctive ocular phenotype.

Ophthalmic genetics
2019

Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation.

Archives of dermatological research
2019

Phenotypic and mutational spectrum of thirty-five patients with Sjögren-Larsson syndrome: identification of eleven novel ALDH3A2 mutations and founder effects.

Journal of human genetics
2019

Retinal Morphology in Sjögren-Larsson Syndrome on OCT: From Metabolic Crystalline Maculopathy to Early-Onset Macular Degeneration.

Ophthalmology. Retina
2019

The combination of whole-exome sequencing and clinical analysis allows better diagnosis of rare syndromic retinal dystrophies.

Acta ophthalmologica
2019

Daily Functioning and Quality of Life in Patients with Sjögren-Larsson Syndrome.

Neuropediatrics
2018

[Sjögren-Larsson syndrome: Pediatric case report].

Archivos argentinos de pediatria
2018

[A new mutation in the ALDH3A2 gene in a boy with Sjogren-Larsson syndrome].

Revista de neurologia
2019

Genotype and phenotype variability in Sjögren-Larsson syndrome.

Human mutation
2018

Sjogren-Larsson Syndrome: A Rare Case Report.

Indian dermatology online journal
2018

Late-Stage Sjögren-Larsson Syndrome Maculopathy Imaged With OCT Angiography.

Ophthalmic surgery, lasers &amp; imaging retina
2018

Neurodegeneration in an adolescent with Sjogren-Larsson syndrome: a decade-long follow-up case report.

BMC medical genetics
2019

Neural symptoms in a gene knockout mouse model of Sjögren-Larsson syndrome are associated with a decrease in 2-hydroxygalactosylceramide.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2018

Neuro-ichthyotic Syndromes: A Case Series.

Journal of pediatric neurosciences
2018

Typical clinical and neuroimaging features in Sjögren-Larsson syndrome.

Arquivos de neuro-psiquiatria
2018

Clinical and molecular characterization and response to acitretin in three families with Sjögren-Larsson syndrome.

International journal of dermatology
2018

Identification of a novel deletion within ALDH3A2 gene in an Iranian Family with Sjögren-Larsson Syndrome.

Clinical case reports
2017

Sjögren-Larsson syndrome: definitive diagnosis on magnetic resonance spectroscopy.

Cutis
2018

Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran.

European journal of medical genetics
2017

Atypical Presentation of Sjögren-Larsson Syndrome.

Case reports in pediatrics
2017

Sequence variants in nine different genes underlying rare skin disorders in 10 consanguineous families.

International journal of dermatology
2018

Identification of Homozygous Likely Pathogenic Variant of ALDH3A2 in a Korean Boy with Sjögren-Larsson Syndrome.

Annals of laboratory medicine
2018

Understanding fetal factors that contribute to preterm birth: Sjögren-Larsson syndrome as a model.

Journal of perinatal medicine
2017

The sphingosine 1-phosphate breakdown product, (2E)-hexadecenal, forms protein adducts and glutathione conjugates in vitro.

Journal of lipid research
2018

Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome.

Clinical genetics
2016

Coexistence of Two Rare Autosomal Recessive Disorders: Activation-Induced Cytidine Deaminase Deficiency and Sjogren-Larsson Syndrome.

The Israel Medical Association journal : IMAJ
2017

Expanding the Genotype of Sjögren-Larsson Syndrome: A New Case Due to Two Novel Mutations.

Actas dermo-sifiliograficas
2017

Lack of Long-Term Neurologic Efficacy of Zileuton in Sjögren-Larsson's Syndrome.

Neuropediatrics
2019

OPHTHALMIC FINDINGS IN LATE STAGE SJOGREN-LARSSON SYNDROME.

Retinal cases &amp; brief reports
2017

Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome.

Journal of child neurology
2017

PNPLA1 is a transacylase essential for the generation of the skin barrier lipid ω-O-acylceramide.

Nature communications
2017

[Anesthesia for an Eleven Year Old Girl with Sjögren-Larsson Syndrome].

Masui. The Japanese journal of anesthesiology
2017

Child Neurology: Sjögren-Larsson syndrome.

Neurology
2017

Unusual presentation Of Sjögren-associated neuropathy with plasma cell-rich infiltrate.

Muscle &amp; nerve
2016

Macular fibrosis complicating macular pigment deficient maculopathy in Sjögren-Larsson syndrome.

Acta ophthalmologica
2016

Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Expert opinion on orphan drugs
2016

A rare case of Sjogren-Larsson syndrome with recurrent pneumonia and asthma.

Korean journal of pediatrics
2016

Sjögren-Larsson Syndrome: A Neuro-Ichthyotic Disorder With Unique Magnetic Resonance Features.

Pediatric neurology
2016

Sjogren-Larsson syndrome: A rare neurocutaneous disorder.

Journal of pediatric neurosciences
2016

Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.

BMJ case reports
2016

Disruption of the Sjögren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery.

The Journal of biological chemistry
2016

Inherited ichthyosis: Syndromic forms.

The Journal of dermatology
2016

Ocular manifestations of genetic skin disorders.

Clinics in dermatology
2015

SAXS fingerprints of aldehyde dehydrogenase oligomers.

Data in brief
2015

A rare cause of pruritic ichthyosis: Sjögren-Larsson syndrome in the first reported patients of Cypriot descent.

European journal of dermatology : EJD
2015

Phytol in a pharma-medico-stance.

Chemico-biological interactions
2015

Changes in the Submandibular Salivary Gland Epithelial Cell Subpopulations During Progression of Sjögren's Syndrome-Like Disease in the NOD/ShiLtJ Mouse Model.

Anatomical record (Hoboken, N.J. : 2007)
2016

Zileuton for Pruritus in Sjögren-Larsson Syndrome: A Randomized Double-blind Placebo-controlled Crossover Trial.

Acta dermato-venereologica
2015

Case of Sjögren-Larsson syndrome with a large deletion in the ALDH3A2 gene confirmed by single nucleotide polymorphism array analysis.

The Journal of dermatology
2015

Segmentation of Retinal Layers in Sjögren-Larsson Syndrome.

Ophthalmology
2015

Single amino acid polymorphism in aldehyde dehydrogenase gene superfamily.

Frontiers in bioscience (Landmark edition)
Ver todos os 326 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Sjögren-Larsson.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Sjögren-Larsson

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Multisystem manifestations of Sj&#xf6;gren-Larsson syndrome in early childhood and its dental implications.
    BMJ case reports· 2026· PMID 41825905mais citado
  2. General Anesthesia for a Child With Sj&#xf6;gren-Larsson Syndrome.
    Anesthesia progress· 2026· PMID 41791722mais citado
  3. Dupilumab Reduces Pruritus in Twins With Sj&#xf6;gren-Larsson Syndrome.
    Pediatric dermatology· 2025· PMID 41046861mais citado
  4. Ciliopathy: Sj&#xf6;gren-Larsson Syndrome.
    Advances in experimental medicine and biology· 2025· PMID 40736838mais citado
  5. Biosynthesis of fatty aldehydes and alcohols in the eye and their role in meibogenesis.
    The Journal of biological chemistry· 2025· PMID 40473210mais citado
  6. Mutation mapping and functional characterization of a missense mutation p.Arg228Cys in ALDH3A2 gene causing Sjögran-Larson syndrome.
    Mol Biol Rep· 2026· PMID 41920227recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:816(Orphanet)
  2. OMIM OMIM:270200(OMIM)
  3. MONDO:0010031(MONDO)
  4. GARD:7654(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q2291208(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Sjögren-Larsson
Compêndio · Raras BR

Síndrome Sjögren-Larsson

ORPHA:816 · MONDO:0010031
Prevalência
1-5 / 10 000
Herança
Autosomal recessive
CID-10
Q87.1 · Síndromes com malformações congênitas associadas predominantemente com nanismo
CID-11
Ensaios
1 ativos
Início
Infancy, Neonatal
Prevalência
16.0 (Taiwan, Province of China)
MedGen
UMLS
C0037231
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades